ESR1 and Hyperglycemia: We also attempted to block the hyperglycaemia-induced EMT phenotype by targeting the lipogenic enzyme fatty acid synthase (FASN) and the downstream ERα which, as previously shown by us, cooperate together to mediate hyperglycaemia-induced chemoresistance in these cells [14,15].